ATYR

aTyr Pharma, Inc. - Common Stock (ATYR)

About aTyr Pharma, Inc. - Common Stock (ATYR)

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Details

Daily high

$3.60

Daily low

$3.47

Price at open

$3.58

52 Week High

$4.66

52 Week Low

$1.42

Market cap

308.3M

Dividend yield

0.00%

Volume

269,332

Avg. volume

1.4M

P/E ratio

-3.99

aTyr Pharma, Inc. - Common Stock News